| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8439637 | European Journal of Cancer | 2018 | 10 Pages |
Abstract
BM management is highly variable in Europe: screening is not uniform, prognostic classifications are not often used and MUT+Â NSCLC patients generally receive more intensive local treatment. Prospective assessment of BM management in MUT+Â NSCLC patients is required.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Antonin Levy, Corinne Faivre-Finn, Baktiar Hasan, Eleonora De Maio, Anna S. Berghoff, Nicolas Girard, Laurent Greillier, Sylvie Lantuéjoul, Mary O'Brien, Martin Reck, Anne-Marie C. Dingemans, Silvia Novello, Thierry Berghmans, Benjamin Besse,